Produced by Araxis Merge on 11/9/2017 4:31:05 PM Central Standard Time. See www.araxis.com for information about Merge. This report uses XHTML and CSS2, and is best viewed with a modern standards-compliant browser. For optimum results when printing this report, use landscape orientation and enable printing of background images and colours in your browser.
# | Location | File | Last Modified |
---|---|---|---|
1 | PPS-N_B397.zip\PPS-N_B397\PPS-N_B397\PS_PPS_ui\src\test\resources\messages | duplicateTherapyBugResponse.xml | Thu Nov 9 15:03:06 2017 UTC |
2 | PPS-N_B397.zip\PPS-N_B397\PPS-N_B397\PS_PPS_ui\src\test\resources\messages | duplicateTherapyBugResponse.xml | Thu Nov 9 21:18:05 2017 UTC |
Description | Between Files 1 and 2 |
|
---|---|---|
Text Blocks | Lines | |
Unchanged | 3 | 230 |
Changed | 2 | 4 |
Inserted | 0 | 0 |
Removed | 0 | 0 |
Whitespace | |
---|---|
Character case | Differences in character case are significant |
Line endings | Differences in line endings (CR and LF characters) are ignored |
CR/LF characters | Not shown in the comparison detail |
No regular expressions were active.
1 | <?xml | |
2 | version="1 .0" | |
3 | encoding=" UTF-8" | |
4 | ?> | |
5 | <PEPSRespo nse | |
6 | ||
7 | xsi:schema Location=" gov/va/med /pharmacy/ peps/exter nal/common /preencaps ulation/vo /drug/chec k/response drugCheck SchemaOutp ut.xsd" | |
8 | ||
9 | xmlns:xsi= "http://ww w.w3.org/2 001/XMLSch ema-instan ce" | |
10 | xmlns="gov /va/med/ph armacy/pep s/external /common/pr eencapsula tion/vo/dr ug/check/r esponse" | |
11 | > | |
12 | ||
13 | <Header> | |
14 | ||
15 | <Time | |
16 | value="084 5" | |
17 | /> | |
18 | ||
19 | <MServer | |
20 | namespace= "VISTA" | |
21 | uci="text" | |
22 | ip=" IP " | |
23 | ||
24 | serverName ="Server N ame" | |
25 | stationNum ber="45" | |
26 | /> | |
27 | ||
28 | <MUser | |
29 | userName=" REDACTED " | |
30 | duz="88660 079" | |
31 | jobNumber= "1002" | |
32 | /> | |
33 | ||
34 | <PEPSVersi on | |
35 | difIssueDa te="200810 20" | |
36 | difBuildVe rsion="6" | |
37 | difDbVersi on="3.2" | |
38 | /> | |
39 | ||
40 | </Header> | |
41 | ||
42 | <Body> | |
43 | ||
44 | <drugCheck > | |
45 | ||
46 | <drugThera pyChecks> | |
47 | ||
48 | <drugThera pyCheck> | |
49 | ||
50 | <interacte dDrugList> | |
51 | ||
52 | <drug | |
53 | orderNumbe r="Z;2;Pro spect" | |
54 | ien="93268 " | |
55 | gcnSeqNo=" 24538" | |
56 | /> | |
57 | ||
58 | <drug | |
59 | orderNumbe r="Z;1;Pro spect" | |
60 | ien="344" | |
61 | gcnSeqNo=" 58432" | |
62 | /> | |
63 | ||
64 | </interact edDrugList > | |
65 | ||
66 | <classific ation> | |
67 | Calcium Ch annel Bloc kers | |
68 | </classifi cation> | |
69 | ||
70 | <duplicate Allowance> | |
71 | 0 | |
72 | </duplicat eAllowance > | |
73 | ||
74 | <shortText > | |
75 | Use of DIL TIAZEM HCL ORAL CAPS ULE,SUSTAI NED ACTION 240 MG an d AMLODIPI NE BESYLAT E/ATORVAST ATIN CALCI UM ORAL TA BLET 2.5 M G-10 MG ma y represen t a duplic ation in t herapy bas ed on thei r associat ion to the therapeut ic drug cl ass Calciu m Channel Blockers. | |
76 | </shortTex t> | |
77 | ||
78 | </drugTher apyCheck> | |
79 | ||
80 | <drugThera pyCheck> | |
81 | ||
82 | <interacte dDrugList> | |
83 | ||
84 | <drug | |
85 | orderNumbe r="Z;2;Pro spect" | |
86 | ien="93267 " | |
87 | gcnSeqNo=" 16579" | |
88 | /> | |
89 | ||
90 | <drug | |
91 | orderNumbe r="Z;1;Pro spect" | |
92 | ien="344" | |
93 | gcnSeqNo=" 58432" | |
94 | /> | |
95 | ||
96 | </interact edDrugList > | |
97 | ||
98 | <classific ation> | |
99 | HMGCo-A Re ductase In hibitors | |
100 | </classifi cation> | |
101 | ||
102 | <duplicate Allowance> | |
103 | 0 | |
104 | </duplicat eAllowance > | |
105 | ||
106 | <shortText > | |
107 | Use of SIM VASTATIN O RAL TABLET 40 MG and AMLODIPIN E BESYLATE /ATORVASTA TIN CALCIU M ORAL TAB LET 2.5 MG -10 MG may represent a duplica tion in th erapy base d on their associati on to the therapeuti c drug cla ss HMGCo-A Reductase Inhibitor s. | |
108 | </shortTex t> | |
109 | ||
110 | </drugTher apyCheck> | |
111 | ||
112 | </drugTher apyChecks> | |
113 | ||
114 | </drugChec k> | |
115 | ||
116 | </Body> | |
117 | </PEPSResp onse> |
Araxis Merge (but not the data content of this report) is Copyright © 1993-2016 Araxis Ltd (www.araxis.com). All rights reserved.